Do you want to read an article? Please log in or register.
Exposure to Intravenous Opioids is Associated With Future Exposure to Opioids in Hospitalized Patients With Inflammatory Bowel Diseases
Inflammatory Bowel Disease
Related content
Inflammatory Bowel Disease
Preadmission Cannabis Use Is Positively Correlated With Inpatient Opioid Dose Exposure in Hospitalized Patients With Inflammatory Bowel Diseases
Inflamm Bowel Dis.
Dalal RS, Palchaudhuri S, Snider CK, Lewis JD, Mehta SJ, Lichtenstein GR
doi: 10.1093/ibd/izaa104.
RECOMMENDED
Inflammatory Bowel Disease
No Association Between Pseudopolyps and Colorectal Neoplasia in Patients With Inflammatory Bowel Diseases
doi: 10.1053/j.gastro.2018.11.067.
Inflammatory Bowel Disease
High Patient Activation Is Associated With Remission in Patients With Inflammatory Bowel Disease
Inflamm Bowel Dis.
Barnes EL, Long MD, Kappelman MD, Martin CF, Sandler RS
doi: 10.1093/ibd/izy378.
Inflammatory Bowel Disease
Association of Genetic Variants in NUDT15 With Thiopurine-Induced Myelosuppression in Patients With Inflammatory Bowel Disease
JAMA.
Walker GJ, Harrison JW, Heap GA, Voskuil MD, Andersen V, Anderson CA, Ananthakrishnan AN, Barrett JC, Beaugerie L, Bewshea CM, Cole AT, Cummings FR, Daly MJ, Ellul P, Fedorak RN, Festen EAM, Florin TH, Gaya DR, Halfvarson J, Hart AL, Heerasing NM, Hendy P, Irving PM, Jones SE, Koskela J, Lindsay JO, Mansfield JC, McGovern D, Parkes M, Pollok RCG, Ramakrishnan S, Rampton DS, Rivas MA, Russell RK, Schultz M, Sebastian S, Seksik P, Singh A, So K, Sokol H, Subramaniam K, Todd A, Annese V, Weersma RK, Xavier R, Ward R, Weedon MN, Goodhand JR, Kennedy NA, Ahmad T; IBD Pharmacogenetics Study Group
doi: 10.1001/jama.2019.0709.
Inflammatory Bowel Disease
Risk of Venous Thromboembolism After Hospital Discharge in Patients With Inflammatory Bowel Disease: A Population-based Study
Inflamm Bowel Dis.
McCurdy JD, Kuenzig ME, Smith G, Spruin S, Murthy SK, Carrier M, Nguyen GC, Benchimol EI
doi: 10.1093/ibd/izaa002.
Inflammatory Bowel Disease
Increased incidence of systemic serious viral infections in patients with inflammatory bowel disease associates with active disease and use of thiopurines
United European Gastroenterol J.
Wisniewski A, Kirchgesner J, Saint-Antoine IBD network.
doi: 10.1177/2050640619889763.
Inflammatory Bowel Disease
Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre
United European Gastroenterol J.
Scaldaferri F, Pugliese D, Privitera G, Onali S, Lopetuso LR, Rizzatti G, Settanni CR, Pizzoferrato M, Schiavoni E, Turchini L, Amatucci V, Napolitano D, Bernabei T, Mora V, Laterza L, Papa A, Guidi L, Rapaccini GL, Gasbarrini A, Armuzzi A
doi: 10.1177/2050640620929133.
COMMENTED
Inflammatory Bowel Disease
Corticosteroids, but not TNF Antagonists, are Associated with Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results from an International Registry
★ 3
Recommended and commented by
PD Dr Luc Biedermann, Faculty Member
★ 3
Recommended by
Prof. Dr Stephan Vavricka, Faculty Member
Gastroenterology.
Brenner EJ, Ungaro RC, Gearry RB, Kaplan GG, Kissous-Hunt M, Lewis JD, Ng SC, Rahier JF, Reinisch W, Ruemmele FM, Steinwurz F, Underwood FE, Zhang X, Colombel JF, Kappelman MD
doi: 10.1053/j.gastro.2020.05.032.
Inflammatory Bowel Disease
Vegetarian or gluten-free diets in patients with inflammatory bowel disease are associated with lower psychological well-being and a different gut microbiota, but no beneficial effects on the course of the disease
United European Gastroenterol J.
Schreiner P, Yilmaz B, Rossel JB, Franc Y, Misselwitz B, Scharl M, Zeitz J, Frei P, Greuter T, Vavricka SR, Pittet V, Siebenhüner A, Juillerat P, von Känel R, Macpherson AJ, Rogler G, Biedermann L, Swiss IBD Cohort Study Group.
doi: 10.1177/2050640619841249.